Leading Financial Service Provider in India | Canara Bank Securities Ltd

KREBS BIOCHEMICALS & INDUSTRIES LTD.

NSE CodeKREBSBIOEQ
BSE Code524518
ISININE268B01013
IndustryPharmaceuticals

55.88-0.28 (-0.50%) In BSE

50 Volume

55.88 Open Price

56.16 Prev. Close

56.30 (105) Bid. Price (Qty.)

59.74 (10) Offer. Price (Qty.)

55.88

Today's Low / High

55.88

76.72

52 Wk Low / High

38.52

View Chart

57.51-0.35 (-0.60%) In NSE

312 Volume

57.80 Open Price

57.86 Prev. Close

57.50 (380) Bid. Price (Qty.)

57.51 (99) Offer. Price (Qty.)

58.78

Today's Low / High

56.26

76.85

52 Wk Low / High

38.33

View Chart

Corporate News

Krebs Biochem.&Ind. - Copy of Newspaper Publication

30-Oct-2026|11:08AM

Krebs Biochemicals and Industries Limited has informed the Exchange about C

Krebs Biochem.&Ind. posts Q2 net loss of Rs 5.40 cr

29-Oct-2026|2:20PM

The company reported standalone net loss during the quarter stood at Rs 5.4

Krebs Biochem.&Ind. - Outcome of Board Meeting

29-Oct-2026|1:11PM

Krebs Biochemicals and Industries Limited has submitted to the Exchange, th

Krebs Biochem.&Ind. - Result For The Quarter Ended 30...

29-Oct-2026|1:06PM

Financial Results for the quarter ended 30.09.2026

	Promoters 15,684,134	72.74%
	Institutional Investors 106,822	0.50%
	Other Investors 1,537,729	7.13%
	General Public 4,231,901	19.63%

Peer Comparison

Company Name	Price (₹)	Market Cap(₹ Cr)
Aarey Drug	106.86	302.99
Aarti Drug	446.35	4,073.84
Aarti Pharma	903.35	8,191.56
Abbott India	26,675.00	56,682.51
Accent Micro	610.00	1,463.33

MF Holding

No Data Available

Board Meetings

Date	Purpose
29/10/2026	Quarterly Results
06/08/2026	Quarterly Results
21/05/2026	Audited Results
09/02/2026	Quarterly Results &..
04/11/2025	Quarterly Results

Markets

KREBS BIOCHEMICALS & INDUSTRIES LTD.

Company Information

Management

Mr. Rakesh R Kalbate

Mr. Ritesh Jain

Incorporation Year

Registered Address

Registrar Office

Email

Website

Listing